Joel Bennett Braunstein
Fondateur chez LifeTech Research, Inc.
Profil
Joel Bennett Braunstein is the founder of LifeTech Research, Inc. where he serves as the Chief Executive Officer starting in 2003.
He is also the founder of LifeTech Development Partners LP, where he holds the position of Managing Partner starting in 2008.
In 2007, he founded C2N Diagnostics LLC and serves as the President, Chief Executive Officer & Director.
Dr. Braunstein was also the founder of Tivorsan Pharmaceuticals, Inc. Dr. Braunstein's current job was as the President & Chief Executive Officer at Centegen, Inc.His former positions included Chairman at NexGen Medical Systems, Inc., Director at NexGen Medical Systems, Inc., and Director at Correx, Inc.Dr. Braunstein obtained a doctorate degree from Northwestern University in 1996 and an MBA from The Johns Hopkins University in 2003.
Postes actifs de Joel Bennett Braunstein
| Sociétés | Poste | Début |
|---|---|---|
LifeTech Research, Inc.
 LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Fondateur | 01/01/2003 |
Centegen, Inc.
 Centegen, Inc. BiotechnologyHealth Technology Centegen, Inc. develops novel therapeutics to fight serious drug resistant bacterial infections. The company was founded by Dr. Joel B. Braunstein and is headquartered in Pikesville, MD. | Directeur Général | - |
LifeTech Development Partners LP
 LifeTech Development Partners LP Investment ManagersFinance LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland. | Fondateur | 01/01/2008 |
C2N Diagnostics LLC
 C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Fondateur | 01/01/2007 |
Anciens postes connus de Joel Bennett Braunstein
| Sociétés | Poste | Fin |
|---|---|---|
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Fondateur | 01/12/2019 |
NexGen Medical Systems, Inc.
 NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Président | - |
Correx, Inc.
 Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | - |
NexGen Medical Systems, Inc.
NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Directeur/Membre du Conseil | - |
Formation de Joel Bennett Braunstein
| Northwestern University | Doctorate Degree |
| The Johns Hopkins University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
LifeTech Research, Inc.
LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Finance |
Centegen, Inc.
Centegen, Inc. BiotechnologyHealth Technology Centegen, Inc. develops novel therapeutics to fight serious drug resistant bacterial infections. The company was founded by Dr. Joel B. Braunstein and is headquartered in Pikesville, MD. | Health Technology |
LifeTech Development Partners LP
LifeTech Development Partners LP Investment ManagersFinance LifeTech Development Partners LP (LifeTech Development) is a venture capital subsidiary of LifeTech Research, Inc. founded in 2008 by Joel Braunstein. The firm is headquartered in Baltimore, Maryland. | Finance |
NexGen Medical Systems, Inc.
NexGen Medical Systems, Inc. Medical SpecialtiesHealth Technology NexGen Medical Systems, Inc. develops medical devices that enhance the safety and effectiveness of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The firm focuses on commercializing an integrated medical device product line for removal of blood clots from head, neck, and peripheral vessels. The company was founded by Richard E. Latchaw, John Kucharczyk and George T. Gillies and is headquartered in Wayzata, MN. | Health Technology |
Correx, Inc.
Correx, Inc. Medical SpecialtiesHealth Technology Correx, Inc. manufactures surgical devices for aortic valve bypass (AVB) surgeries. The company was founded by Joseph L. Smith Jr., Richard M. Beane, James S. Gammie, and John W. Brown in 2004 and is headquartered in Waltham, MA. | Health Technology |
Tivorsan Pharmaceuticals, Inc.
Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Health Technology |
C2N Diagnostics LLC
C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Health Technology |